Company registration number SC753598 (Scotland)
PLATINUM MEDICAL CONSULTANCY LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023
PAGES FOR FILING WITH REGISTRAR
PLATINUM MEDICAL CONSULTANCY LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
PLATINUM MEDICAL CONSULTANCY LTD
BALANCE SHEET
AS AT
31 DECEMBER 2023
31 December 2023
- 1 -
2023
Notes
£
£
Fixed assets
Tangible assets
4
77,131
Current assets
Debtors
5
3,592
Cash at bank and in hand
4,183
7,775
Creditors: amounts falling due within one year
6
(15,047)
Net current liabilities
(7,272)
Total assets less current liabilities
69,859
Creditors: amounts falling due after more than one year
7
(82,373)
Net liabilities
(12,514)
Capital and reserves
Called up share capital
8
100
Profit and loss reserves
(12,614)
Total equity
(12,514)

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 26 July 2024
Dr S Watkins
Director
Company Registration No. SC753598
PLATINUM MEDICAL CONSULTANCY LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023
- 2 -
1
Accounting policies
Company information

Platinum Medical Consultancy Ltd is a private company limited by shares incorporated in Scotland. The registered office is 3 Wellington Square, Ayr, Ayrshire, United Kingdom, KA7 1EN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

At the year end, the company had net liabilities of £12,514. The director has confirmed that they will continue to provide financial support to the company until such time that the financial position improves. The director therefore considers it appropriate to prepare the financial statements on a going concern basis.true

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
20% Straight-Line Method
Motor vehicles
25% Reducing Balance Method
2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2023
Number
Total
1
3
Taxation
PLATINUM MEDICAL CONSULTANCY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2023
- 3 -
4
Tangible fixed assets
Computers
Motor vehicles
Total
£
£
£
Cost
At 21 December 2022
-
0
-
0
-
0
Additions
1,399
101,100
102,499
At 31 December 2023
1,399
101,100
102,499
Depreciation and impairment
At 21 December 2022
-
0
-
0
-
0
Depreciation charged in the period
93
25,275
25,368
At 31 December 2023
93
25,275
25,368
Carrying amount
At 31 December 2023
1,306
75,825
77,131
5
Debtors
2023
Amounts falling due within one year:
£
Trade debtors
3,372
Other debtors
220
3,592
6
Creditors: amounts falling due within one year
2023
£
Obligations under finance leases
11,877
Other creditors
1,970
Accruals and deferred income
1,200
15,047
7
Creditors: amounts falling due after more than one year
2023
£
Obligations under finance leases
82,373
PLATINUM MEDICAL CONSULTANCY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2023
- 4 -
8
Called up share capital
2023
2023
Ordinary share capital
Number
£
Issued and fully paid
Ordinary shares of £1 each
100
100
2023-12-312022-12-21false26 July 2024CCH SoftwareCCH Accounts Production 2024.100No description of principal activityDr S WatkinsfalsefalseSC7535982022-12-212023-12-31SC7535982023-12-31SC753598core:ComputerEquipment2023-12-31SC753598core:MotorVehicles2023-12-31SC753598core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-31SC753598core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-31SC753598core:CurrentFinancialInstruments2023-12-31SC753598core:ShareCapital2023-12-31SC753598core:RetainedEarningsAccumulatedLosses2023-12-31SC753598bus:Director12022-12-212023-12-31SC753598core:ComputerEquipment2022-12-212023-12-31SC753598core:MotorVehicles2022-12-212023-12-31SC753598core:ComputerEquipment2022-12-20SC753598core:MotorVehicles2022-12-20SC7535982022-12-20SC753598core:WithinOneYear2023-12-31SC753598core:Non-currentFinancialInstruments2023-12-31SC753598bus:PrivateLimitedCompanyLtd2022-12-212023-12-31SC753598bus:SmallCompaniesRegimeForAccounts2022-12-212023-12-31SC753598bus:FRS1022022-12-212023-12-31SC753598bus:AuditExemptWithAccountantsReport2022-12-212023-12-31SC753598bus:FullAccounts2022-12-212023-12-31xbrli:purexbrli:sharesiso4217:GBP